Clinical Trials Browser

INDUSTRY × Radiodermatitis × Clear all

NCT07192588 2025-09-25

GuARD

Phase 2 Active not recruiting

Breast Neoplasms, Radiodermatitis

NCT02142959 2025-06-03

RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE

Phase 2 Completed

187 enrolled 11 charts

Breast Neoplasms, Inflammation, Radiodermatitis

NCT05553392 2024-09-04

StrataXRT Versus Aquaphor for the Prevention and Management of Radiation Dermatitis

Phase NA Terminated

Radiodermatitis

NCT05284487 2024-02-26

JALOSOME-01

Phase NA Unknown

Radiodermatitis

NCT04261387 2022-07-27

LUT014 for the Treatment of Radiation Induced Dermatitis in Breast Cancer Patients

Phase 1/2 Completed

Breast Neoplasms, Dermatitis, Radiodermatitis

NCT04692389 2022-02-08

Jalosome® Soothing Gel Efficacy Grade 2 or 3 Radiodermatitis.

Phase NA Withdrawn

Neoplasms, Pain, Radiodermatitis

NCT04481802 2021-07-21

The Effect of RadiaAce Gel in the Prevention and Treatment of Radiation Dermatitis in Breast Cancer Patients

Phase NA Unknown

Breast Neoplasms, Radiodermatitis

NCT03988556 2021-04-30

SafePBM

Phase NA Completed

BreastHead & Neck

Breast Neoplasms, Head and Neck Neoplasms, Radiodermatitis, Stomatitis

NCT03255980 2020-12-16

Monocenter, Open Label Clinical Investigation on the Treatment of Radiation Induced Dermatitis With Xonrid®

Phase NA Completed

80 enrolled 9 charts

Radiodermatitis

NCT01714973 2019-05-13

Study of ST266 Versus Saline in Treating Skin Irritation From Radiation

Phase 1 Completed

Radiodermatitis

NCT02534129 2017-10-06

Topical Use of Difinsa53™ to Prevent Radiation Dermatitis

Phase 1/2 Terminated

13 enrolled 3 charts

Breast Neoplasms, Dermatitis, Radiodermatitis

NCT02289365 2016-06-15

Orally Administrated JBM-TC4 Prevents Acute Radiodermatitis in Breast Cancer Patients

Phase 2 Unknown

Breast Neoplasms, Radiodermatitis

NCT01923220 2013-08-15

ARD

Phase EARLY_PHASE1 Unknown

Breast Neoplasms, Radiodermatitis

NCT01513278 2013-07-15

Study of APN201 (Liposomal Recombinant Human Cu/Zn-Superoxide Dismutase) for the Prevention of Radiation-induced Dermatitis in Women With Breast Cancer

Phase 1/2 Completed

Radiodermatitis

NCT01263366 2013-04-19

Exploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer Patients

Phase 1 Terminated

Radiodermatitis

NCT01597921 2012-08-09

A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer

Breast Neoplasms, Erythema, Radiodermatitis

NCT01544504 2012-05-28

Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy

Phase 1/2 Withdrawn

Radiodermatitis

NCT01367990 2012-03-23

Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy

Phase 1 Terminated

Alopecia, Head and Neck Neoplasms, Radiodermatitis